MYC and neoplasm: Therefore inhibition of Cdk1, Cdk2 or combinationof these regimens should be considered in future treatment of Myc driven tumorsbased on molecular diagnosis of genetic and epigenetic status of intrinsictumor suppressor systems of the tumor cells (Figure 1B).